Home » Newsletters » BioWorld Science

BioWorld Science

March 17, 2021

View Archived Issues

Linking antiphospholipid antibodies to autoimmunity

Lipid dysregulation gives information on Parkinson's

Immune system, treatment, in kidney cancer

Moderna initiates phase I study of its next-generation COVID-19 vaccine, mRNA-1283

Multimorbid diseases cluster in predictable ways: study

Pliant completes phase I study of PLN-1474 and transfers the candidate to Novartis

First patients dosed in global phase I study of ADG-126

First patient dosed in phase I study of emricasan in mild symptomatic COVID-19

Arbutus receives regulatory approval for phase Ia/Ib trial of AB-836 in chronic HBV infection

Galmed initiates dosing in first-in-human phase I trial of Amilo-5MER

FDA clears IND for phase II study of CYTO-205 as treatment of mild COVID-19

AB-205 eliminates oral and gastrointestinal SRRT in adults undergoing HDT-AHCT

UCB describes new antimalarial compounds

KalVista Pharmaceuticals discovers FXIIa inhibitors

Otsuka Pharmaceutical, Taiho Pharmaceutical patent PTPN11 inhibitors

New anti-SIRP-alpha antibodies described by Elpiscience BioPharma

First-in-human results presented for R-552 in healthy adults

Biohaven Therapeutics identifies compounds targeting TDP-43

Study reveals dose finding for gevokizumab in oncology

THCVHS shows no signs of eye irritation in in vitro assay

French clearance for first-in-human study of PEP-010 in advanced solid tumors

Phase Ib data with VS-01 support advancement to phase IIa for acute on chronic liver failure

Corat gains clearances to begin phase Ib/II trial of COR-101 for COVID-19

HTI vaccines show promise for virus control without ART in patients with early HIV infection

Clinical trial collaboration supports new phase II study of Tabrecta and Nerlynx in breast cancer

Annovis reports phase IIa interim data on ANVS-401 in Parkinson's patients

MaaT reports phase II topline data on MaaT-013 in steroid-refractory GI acute GvHD

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...